/Investor DB

Morgan Stanley — 2018 Investments

4 investments dated 2018 · listed companies and verified rows first · show all

Crux Informaticscruxinformatics.comin𝕏Sep 2018

Crux operates a platform for onboarding, monitoring, and delivering external data, using AI-driven automation for data ingestion, schema mapping, and real-time validation.

AI & Machine LearningData & InfrastructureSaaSSan Francisco, US

Philip Brittan(Executive Officer, Director)inAli-Milan Nekmouche(Director)Robert Hengartner(Director)Bruce Macurda(Executive Officer)Andrew Janian(Director)Lawrence Leibowitz(Executive Officer, Director)

Co-investorsSenaHill PartnersGoldman Sachs

myLAB Boxmylabbox.comin𝕏Aug 2018

myLAB Box offers at-home test kits for sexually transmitted infections and related sexual health conditions, letting consumers screen for infections such as chlamydia, gonorrhea, HIV, HPV, and syphilis without visiting a clinic.

Digital HealthDirect to ConsumerHealthtechLos Angeles, US

Ursula Hessenflow-Cruz(Founder)inLora Ivanova(Co-founder)Ursula Hessenflow(Co-founder)inStephen Block(Director)

Co-investorsEvolution VC PartnersFrontera Technology VenturesHouston Angel NetworkKickstart InnovationPasadena AngelsSand Hill Angels+5 more

Visiblevisible.vcinJan 2018 · $38M

Visible provides a platform for founders to send regular investor updates, manage investor relationships, and run fundraising processes.

AI & Machine LearningData & InfrastructureFintechSaaS

Co-investorsConnetic VenturesHigh AlphaKima VenturesBank of AmericaGoldman SachsJefferies+4 more

Visiblemakevisible.com𝕏Jan 2018 · $38M

A company focused on improving understanding of energy-limiting, often invisible chronic conditions such as Long Covid and ME, which it states affect over 100 million people.

Digital HealthHardwareHealthtechWellness & Fitness

Harry Leeming(Founder)inLuke Martin-Fuller(Founder)in

Co-investorsCalm/Storm VCCircle & Co.Flexcap VenturesOctopus VenturesBank of AmericaGoldman Sachs+6 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.